Catalent takes over Aptuit clinical trial supplies business
The acquisition is expected to expand Catalent’s development & clinical services business and enhance its position in development solutions and advanced delivery technologies for drugs, biologics, and consumer
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.